ConductScience.org, home

Paper39005671

Potential roles of UCH family deubiquitinases in tumorigenesis and chemical inhibitors developed against them.

Xu Z and 2 others. Am J Cancer Res, 2024. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Potential roles of UCH family deubiquitinases in tumorigenesis and chemical inhibitors developed against them. Papers, record 39005671. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39005671

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Potential roles of UCH family deubiquitinases in tumorigenesis and chemical inhibitors developed against them.
PubMed
Journal
Am J Cancer Res
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
2.67, provisional
iCite
Revised in PubMed
2024-07-16
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xu ZZhuo
2Zhang NNaixia
3Shi LLi

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References153

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130349006Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1.Nat Commun2018https://conductscience.org/library/papers/30349006PubMed
220302916The potential role of ubiquitin c-terminal hydrolases in oncogenesis.Biochim Biophys Acta2010https://conductscience.org/library/papers/20302916PubMed
332669118ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer.Genome Med2020https://conductscience.org/library/papers/32669118PubMed
417761421Identification of novel chemical inhibitors for ubiquitin C-terminal hydrolase-L3 by virtual screening.Bioorg Med Chem2007https://conductscience.org/library/papers/17761421PubMed
519536331Positive reciprocal regulation of ubiquitin C-terminal hydrolase L1 and beta-catenin/TCF signaling.PLoS One2009https://conductscience.org/library/papers/19536331PubMed
627264969The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells.Sci Rep2016https://conductscience.org/library/papers/27264969PubMed
722935333BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.J Transl Med2012https://conductscience.org/library/papers/22935333PubMed
831113933A novel UCHL3 inhibitor, perifosine, enhances PARP inhibitor cytotoxicity through inhibition of homologous recombination-mediated DNA double strand break repair.Cell Death Dis2019https://conductscience.org/library/papers/31113933PubMed
929454609Deubiquitinase inhibitor b-AP15 activates endoplasmic reticulum (ER) stress and inhibits Wnt/Notch1 signaling pathway leading to the reduction of cell survival in hepatocellular carcinoma cells.Eur J Pharmacol2018https://conductscience.org/library/papers/29454609PubMed
1019188440Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1.Mol Cell Biol2009https://conductscience.org/library/papers/19188440PubMed
1125283999Stabilization and targeting of INO80 to replication forks by BAP1 during normal DNA synthesis.Nat Commun2014https://conductscience.org/library/papers/25283999PubMed
1226437366Loss of BAP1 function leads to EZH2-dependent transformation.Nat Med2015https://conductscience.org/library/papers/26437366PubMed
1325702872Structural basis for the activation and inhibition of the UCH37 deubiquitylase.Mol Cell2015https://conductscience.org/library/papers/25702872PubMed
1432125598Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma.Invest New Drugs2020https://conductscience.org/library/papers/32125598PubMed
1534757486Ubiquitin C-terminal hydrolase-L1 expression in non-small-cell lung cancer and its association with clinicopathological features and prognosis.Virchows Arch2022https://conductscience.org/library/papers/34757486PubMed
1630202049BAP1 links metabolic regulation of ferroptosis to tumour suppression.Nat Cell Biol2018https://conductscience.org/library/papers/30202049PubMed
1724332045A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer.Cancer Cell2013https://conductscience.org/library/papers/24332045PubMed
1832296023The role of ubiquitination in tumorigenesis and targeted drug discovery.Signal Transduct Target Ther2020https://conductscience.org/library/papers/32296023PubMed
1924703950Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.Mol Cell2014https://conductscience.org/library/papers/24703950PubMed
2026719535Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.Cancer Res2016https://conductscience.org/library/papers/26719535PubMed

See all 153 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42941987Systematic Identification of Candidate Substrates of the UCH Family of Deubiquitinases.Int J Mol Sci2026https://conductscience.org/library/papers/42941987PubMed
42941729The Proliferation-Invasion Dichotomy: Transcriptomic Signatures of lncRNA and Ubiquitin-Proteasome Networks in Hypermutated Endometrial Cancer.Int J Mol Sci2026https://conductscience.org/library/papers/42941729PubMed
42939974UCHL1 Promotes Epithelial-Mesenchymal Transition Through E-Cadherin and N-Cadherin Switch in Endometrial Cancer.Biomedicines2026https://conductscience.org/library/papers/42939974PubMed
42724680Pathological role of deubiquitinating enzymes in lung cancer: recent insights and advances.Am J Cancer Res2026https://conductscience.org/library/papers/42724680PubMed
42548254The Emerging Role of UCHL1 in Neurological and Musculoskeletal Diseases.Immunol Cell Biol2026https://conductscience.org/library/papers/42548254PubMed
42169250UCHL3 drives ferroptosis in nucleus pulposus cells by deubiquitinating HMGB1 to activate NCOA4-mediated ferritinophagy.Autophagy2026https://conductscience.org/library/papers/42169250PubMed
42138186Deubiquitinating enzymes in cervical cancer: Molecular mechanisms and therapeutic implications (Review).Int J Oncol2026https://conductscience.org/library/papers/42138186PubMed
41861659UCHL1 promotes temozolomide resistance in glioblastoma by inhibiting the ubiquitination-mediated degradation of keratin 8.Transl Oncol2026https://conductscience.org/library/papers/41861659PubMed
41820631Ubiquitin C-terminal hydrolase L3 promotes liver cancer cell proliferation by modulating the AMP-activated protein kinase signaling pathway.J Cancer Res Clin Oncol2026https://conductscience.org/library/papers/41820631PubMed
41664693
Ubiquitin C-terminal hydrolase L5 promotes the development of renal cell carcinoma through the glycolysis mediated by the phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin pathway.
Cytojournal2025https://conductscience.org/library/papers/41664693PubMed
41484776BAP1-mediated stabilization of SUFU enhances E2F1 activity and promotes colorectal tumorigenesis.Cell Commun Signal2026https://conductscience.org/library/papers/41484776PubMed
41155583UCHL1 Promotes Gastric Cancer Progression by Regulating CIP2A Degradation.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41155583PubMed
40691601UCHL3: a crucial deubiquitinase in DNA damage repair and tumor progression.Cancer Cell Int2025https://conductscience.org/library/papers/40691601PubMed
40689350UCHL3 regulates snail stability and promotes epithelial-mesenchymal transition in ovarian cancer.Cytotechnology2025https://conductscience.org/library/papers/40689350PubMed
40141757Proteasomes and Ubiquitin C-Terminal Hydrolase L1 as Biomarkers of Tissue Damage and Inflammatory Response to Different Types of Injury-A Short Review.Life (Basel)2025https://conductscience.org/library/papers/40141757PubMed
39702250Comprehensive pan-cancer analysis indicates UCHL5 as a novel cancer biomarker and promotes cervical cancer progression through the Wnt signaling pathway.Biol Direct2024https://conductscience.org/library/papers/39702250PubMed
39678489Deubiquitinases as novel therapeutic targets for diseases.MedComm (2020)2024https://conductscience.org/library/papers/39678489PubMed
39626954Ubiquitin-Proteasome System in Periodontitis: Mechanisms and Clinical Implications.Cell Prolif2025https://conductscience.org/library/papers/39626954PubMed
39605891Dysregulation of deubiquitinases in gastric cancer progression.Front Oncol2024https://conductscience.org/library/papers/39605891PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BAP18314PubTator's text mininghttps://conductscience.org/library/genes/8314NCBI Gene
UCHL17345PubTator's text mininghttps://conductscience.org/library/genes/7345NCBI Gene
UCHL37347PubTator's text mininghttps://conductscience.org/library/genes/7347NCBI Gene
UCHL551377PubTator's text mininghttps://conductscience.org/library/genes/51377NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39005671

GET https://conductscience.org/api/papers/v1/39005671/references?page=2